Bumetrizole

Bumetrizole

SCHEMBL1792777

Cc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(C)C)c1.Oc1ccccc1-n1nnc2ccccc21

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNMA1 Q12791 2/20 0.48
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.37
▸ ATM Q13315 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ CRHBP P24387 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ CRHR2 Q13324 1/20 0.32
▸ GLA P06280 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ SLC9A1 P19634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bumetrizole SCHEMBL8359542 0.87 NPC1 (0.48) KCNMA1NPC1RAB9ALMNAPOLB
Bumetrizole SCHEMBL6068328 0.86 NPC1 (0.60) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL5353195 0.84 NPC1 (0.60) NPC1RAB9ALMNAPOLBSMN1; SMN2
Bumetrizole SCHEMBL29353083 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL2398487 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL8603228 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL8054070 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL8056551 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
Bumetrizole SCHEMBL23734 0.82 NPC1 (0.53) NPC1RAB9ALMNAPOLBATM
SCHEMBL5031381 0.81 SMN1; SMN2 (0.41) KCNMA1NPC1RAB9APOLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512151-B2 Product containing monomer and polymers of titanyls and methods for making same AUTERRA, INC. (US) 2016-12-06 — — US disclosed
EP-3078726-A1 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME Auterra, Inc. (US) 2016-10-12 — — EP disclosed
EP-2150557-B1 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME AUTERRA INC (US) 2016-07-13 — — EP disclosed
US-20110119988-A1 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME AUTERRA, INC. 2011-05-26 — — US disclosed
EP-2150557-A2 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME Auterra, Inc. (US) 2010-02-10 — — EP disclosed
WO-2008153633-A2 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME APPLIED NANO WORKS, INC. (US) 2008-12-18 — — WO disclosed
US-5476898-A Solution polymerization to form hydroxyl-containing, high solids addition-condensation polymer for polyurethanes SYNTHOPOL CHEMIE DR. RER. POL. KOCH GMBH & CO., KG (DE) 1995-12-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110119988-A1 PRODUCT CONTAINING MONOMER AND POLYMERS OF TITANYLS AND METHODS FOR MAKING SAME NR4A3, NR4A1, RCOR3 KCNMA1 1502/4885NPC1 2418/4885RAB9A 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback